Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity
Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity
复制标题
DOI:
10.1016/j.ejphar.2007.03.023
复制
发表时间:
2007-06-22
影响因子:
5
通讯作者:
Yu, Long
中科院分区:
文献类型:
--
作者:
Chen, Shuai;Zhao, Xuemei;Yu, Long
Cyclophilin A acts as protein folding chaperones and intracellular transports in many cellular processes. Previous studies have shown that cyclophilin A can interact with HIV-1 (human immunodeficiency virus type 1) gag protein and enhance viral infectivity. Many cyclophilin A inhibitors such as cyclosporin A can inhibit HIV-1 replication in vitro. Here, we report a structure-based identification of novel non-peptidic cyclophilin A inhibitors as anti-HIV lead compounds. Following a computer-aided virtual screening and subsequent surface plasmon resonance (SPR) analysis, 12 low molecular weight cyclophilin A ligands were selected for further evaluation of their in vitro inhibition of peptidyl-prolyl cis-trans isomerase (PPlase) activity of cyclophilin A and HIV-1 replication. Five of these compounds (FD5, FD8, FD9, FD10 and FD12) exhibited inhibition against both PPlase activity and HIV-1 infection. These active compounds will be used as leads for structure and activity relationship (SAR) and optimization studies in order to design more effective anti-HIV-1 therapeutics, and as probes for investigating the effect of cyclophilins on HIV-1 replication. (c) 2007 Elsevier B.V. All rights reserved.